Delivery Order SPE2DP16D0008-0047
Award Date
9/8/17
Potential Completion Date
9/10/18
Potential Value
$172K
Federal Agency
Medical Supply Chain
Awardee
Genentech Usa, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency Troop Support Medical awarded a $150,743.97 firm-fixed-price delivery order to Genentech USA, Inc. for the pharmaceutical product oseltamivir phosphate. Genentech is a foreign-owned, for-profit manufacturer of biologics, including antiviral medications like Tamiflu. The contract has a completion date of September 10, 2018 and was awarded on September 8, 2017. This order was placed against one of Genentech's existing indefinite delivery contracts or Federal Supply...
The Defense Logistics Agency Troop Support Medical awarded a Firm Fixed Price Delivery Order contract to Genentech USA, Inc., a foreign-owned for-profit manufacturer of pharmaceuticals, to provide the antiviral medication Oseltamivir Phosphate. The $150,724.74 contract has a completion date of September 24, 2019 and is not designated as a set-aside. Genentech, which has supplied various drugs to U.S. government agencies through indefinite delivery contracts and Federal Supply Schedules, will...
This is a $45,107,051.00 firm fixed-price delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Genentech USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of Oseltamivir Phosphate (Tamiflu) 30mg and 75mg capsules. The award has an ultimate completion date of January 29, 2027 and was made on January 30, 2025. This contract does not utilize any set-aside designations. Genentech has previously held other federal...
This $342,870.90 firm fixed-price delivery order was awarded by the Defense Logistics Agency Troop Support Medical to Genentech USA, Inc., a biotechnology company that manufactures pharmaceuticals. The contract is for the antiviral drug oseltamivir phospha and does not utilize any set-aside designation. Genentech has provided a variety of biologic medicines to government agencies through multiple federal contract vehicles, including the Pharmaceuticals and Drugs Federal Supply Schedule. This...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit biotechnology company. The $93,573.18 firm-fixed-price contract is for the delivery of oseltamivir phosphate, an antiviral medication. The award falls under a larger indefinite delivery contract between Genentech and DLA valued at $27.9 million to supply medical supplies and critical pharmaceuticals for the Department of Defense. No set-aside designation was used....
This is a delivery order awarded to Genentech USA, Inc., a biotechnology company that develops and manufactures pharmaceuticals, by the Defense Logistics Agency Troop Support Medical. The contract is for the antiviral medication oseltamivir phosphate, with a potential value of $468,558.18 and a firm fixed price pricing type. The place of performance is Genentech's facility in South San Francisco, California. The contract does not utilize any set-asides. Genentech has extensive experience...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit manufacturer of pharmaceuticals and biologics. The contract is for the supply of oseltamivir phosphate, an antiviral medication, with a total ceiling value of $259,393.47. The contract is a firm-fixed price delivery order with a completion date of September 20, 2017. Genentech is the prime contractor, and no major subcontractors were identified. The contract is...
This federal contract award was made by the Veterinary Services agency (part of the Department of Agriculture) to Genentech USA, Inc., a foreign-owned, for-profit biotechnology company that manufactures pharmaceuticals. The award is for the delivery of Tamiflu (oseltamivir phosphate) capsules, 75 mg, with a ceiling value of $193,939.20 and a period of performance through December 31, 2020. This appears to be a delivery order issued against a larger contract vehicle, as Genentech holds several...
This is a delivery order under a Federal Supply Schedule contract awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the delivery of oseltamivir phosphate, an antiviral medication, with a ceiling value of $8,434,278.00 and a period of performance ending on September 20, 2017. The contract does not have a set-aside designation. Genentech holds several key contract vehicles with federal agencies,...
This delivery order from the Defense Logistics Agency Troop Support Medical is for four hundred seventy-three dollars to procure Tamiflu 75 mg capsules in blister packs of ten from Genentech USA, Inc. The place of performance is Genentech's facility in South San Francisco, California. The fixed price order is for delivery by August 16, 2022 under a preexisting contract vehicle. No set-aside designation was applied to this award to support DLA Troop Support Medical's stockpiling of antiviral...